Autism Impact Fund, based in San Francisco, is a venture fund that focuses on Pre-Seed, Seed, and Series A stage investments in BioTech, Medical Device, and Pharmaceuticals sectors. The fund, led by Partner Robert Sarrazin, has made 8 investments so far, with portfolio companies like Axial Biotherapeutics. Autism Impact Fund's mission is to invest in life science breakthroughs, therapeutics, and innovative service companies, aiming to improve the quality of life beyond childhood. For more information, visit their website at autismimpact.fund or reach out to Partner Robert Sarrazin via email at rob@autismimpact.fund.